Dose Tapering Study of Adalimumab in Psoriasis

NCT04028713 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

19

Enrollment

OTHER

Sponsor class

Stopped Too slow inclusion rate.

Conditions

Psoriasis Vulgaris

Interventions

PROCEDURE: Venapuncture
PROCEDURE: Dried blood spot
DRUG: Dose reduction

Sponsor

University Hospital, Ghent

Collaborators

[object Object]
[object Object]